Podcasts about global health network

Two weeks ago several G7 leaders called for an international treaty on Pandemic Preparedness for the future. This week 175 prominent leaders called for lifting the IP on vaccine design. And former UK PM Gordon Brown called on the G7 to finance vaccines for the world in the next two months. But are there technical difficulties that limit the pace of manufacture? Anthony McDonnell is an economist at think tank Centre for Global Development who has been looking at the problem since last year. He suggests, amongst other things, one limit is the human expertise in manufacturing these brand-new technologies, with another being a level of vaccine nationalism that is seeing a lack of exports of components involved in manufacture. Professor Trudie Lang heads the University of Oxford’s Global Health Network, and looks at health research across the world. She says in most countries there is no lack of public health or infrastructure potential for rolling out the vaccines, if only the supply existed. The volcano that erupted explosively on St Vincent last week has led to many thousands of people being evacuated. Dr Joan Latchman of the University of West Indies Seismic Research Centre - who has monitored Caribbean volcanos for several decades - describes from Trinidad how the layers of ash mean recovery will take a long time, even if the explosions and pyroclastic dangers subside reasonably soon. Back in The UK, Prof Jenni Barclay and colleagues are examining rocks from the early part of the eruption, before the explosive phase began, to see if there are clues in the microstructure that could provide clues to the future. And how do our brains so quickly tell a scream of delight from a scream of horror? Or of pain? Prof Sascha Frühholz of the University of Geneva has written in the journal PLOS Biology this week about work looking at how we identify the nature of different human screams. One finding is that we perceive joy quicker than fear. Grief is universal. It is something almost all of us will go through at some point. And it is something that the people we love will experience when we die. Grief can be all consuming, it can make everyday tasks like getting out of bed, feel impossible. Which makes listener Oliver from Australia wonder - what is the point? It doesn’t bring what we lost, back. Why have we evolved to be so affected by loss? Be it the death of a loved one, the end of a relationship or the loss of a job. Does it serve any purpose? Or perhaps it is just the price we pay for being a social species with such strong connections. (Image: Getty Images)

Two weeks ago several G7 leaders called for an international treaty on Pandemic Preparedness for the future. This week 175 prominent leaders called for lifting the IP on vaccine design. And former UK PM Gordon Brown called on the G7 to finance vaccines for the world in the next two months. But are there technical difficulties that limit the pace of manufacture? Anthony McDonnell is an economist at think tank Centre for Global Development who has been looking at the problem since last year. He suggests, amongst other things, one limit is the human expertise in manufacturing these brand-new technologies, with another being a level of vaccine nationalism that is seeing a lack of exports of components involved in manufacture. Professor Trudie Lang heads the University of Oxford’s Global Health Network, and looks at health research across the world. She says in most countries there is no lack of public health or infrastructure potential for rolling out the vaccines, if only the supply existed. The volcano that erupted explosively on St Vincent last week has led to many thousands of people being evacuated. Dr Joan Latchman of the University of West Indies Seismic Research Centre - who has monitored Caribbean volcanos for several decades - describes from Trinidad how the layers of ash mean recovery will take a long time, even if the explosions and pyroclastic dangers subside reasonably soon. Back in The UK, Prof Jenni Barclay and colleagues are examining rocks from the early part of the eruption, before the explosive phase began, to see if there are clues in the microstructure that could provide clues to the future. And how do our brains so quickly tell a scream of delight from a scream of horror? Or of pain? Prof Sascha Frühholz of the University of Geneva has written in the journal PLOS Biology this week about work looking at how we identify the nature of different human screams. One finding is that we perceive joy quicker than fear.. (Image: Getty Images) Presenter: Roland Pease Producer: Alex Mansfield

Tracking the virus hunters who race to understand and extinguish new pathogens. Sars Cov 2 is the virus responsible for the pandemic of 2020. But there are millions of other viruses living around the world, any one of which could mutate and infect us at any time. Scientists are in a never-ending race to identify these viruses and contain their dangerous effects. Oxford Professor Trudie Lang, director of the Global Health Network, hears from some of the virus hunters who work against the clock to research and combat these threats. Fighting epidemics requires effort from across the scientific spectrum. What we learn from the outbreak of Covid-19 will be crucial beyond understanding this coronavirus, but also when the next Virus X comes - and it will come. Producer: Sandra Kanthal

The power of crying - Keith Brymer-Jones, one of the judges on the Great Pottery Throw Down, the psychoanalyst and psychotherapist Susie Orbach, and voice coach Joanna Cross discuss. Kathryn Sullivan, the first American woman to walk in space, was an astronaut in the team that launched the Hubble Space Telescope in 1990. After mastectomies the aim is to make breasts look and feel as they did before but sensitivity tends to suffer. Sarafina Nance is leading a campaign to increase understanding of sensitivity and talks about an experimental nerve-preserving procedure she received in the USA last year. We also hear from the breast surgeon Dr Ayesha Khan on treatments available in the UK. Composer Emily Hall on the inspiration behind her piece for the Seven Ages of Women, a new commission by Radio 3 to mark International Women’s Day. Coronavirus – how do you reassure children when everyone is talking about it, and how can they best protect themselves? We hear from Professor Trudie Lang, Director of the Global Health Network at the University of Oxford and Emma Citron, consultant clinical psychologist. Vogue Williams, TV presenter and Instagram influencer on the rise of parent shaming. Celebrating 10 years of the Women of the World Festival - two young activists Eunice Mwende and Dajanaa 'Dexi' Stosic on working to empower young girls and women in Kenya and Serbia. Presenter: Jenni Murray Producer: Dianne McGregor

This webinar features introductions from Francois Van Loggerenberg, scientific lead at the Global Health Network, and community engagement consultant Georgia Bladon to the community engagement platform Mesh. Learn how this platform might be useful to you, how it fits within the Global Health network and what we mean by good community engagement. Plus, take a tour and see examples of the content we create, host and share so that you can add to, use and navigate the site to get the most out of Mesh and your community engagement with health plans.

Dr Trudie Lang tells us how the Global Health Network facilitates collaboration and resource sharing. Clinical trials establish the evidence base for prevention and treatment of disease and are critically important in the field of Global Health. Dr Trudie Lang leads the Global Health Clinical Trials group, which aims to promote and improve the conduct of non-commercial clinical research across all diseases in resource-poor settings.

Dr Trudie Lang tells us how the Global Health Network facilitates collaboration and resource sharing. Clinical trials establish the evidence base for prevention and treatment of disease and are critically important in the field of Global Health. Dr Trudie Lang leads the Global Health Clinical Trials group, which aims to promote and improve the conduct of non-commercial clinical research across all diseases in resource-poor settings.

Dr Trudie Lang tells us how the Global Health Network facilitates collaboration and resource sharing. Clinical trials establish the evidence base for prevention and treatment of disease and are critically important in the field of Global Health. Dr Trudie Lang leads the Global Health Clinical Trials group, which aims to promote and improve the conduct of non-commercial clinical research across all diseases in resource-poor settings.

Dr Trudie Lang tells us how the Global Health Network facilitates collaboration and resource sharing. Clinical trials establish the evidence base for prevention and treatment of disease and are critically important in the field of Global Health. Dr Trudie Lang leads the Global Health Clinical Trials group, which aims to promote and improve the conduct of non-commercial clinical research across all diseases in resource-poor settings.